These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24529931)

  • 21. Post-implantation shear stress assessment: an emerging tool for differentiation of bioresorbable scaffolds.
    Tenekecioglu E; Torii R; Katagiri Y; Chichareon P; Asano T; Miyazaki Y; Takahashi K; Modolo R; Al-Lamee R; Al-Lamee K; Colet C; Reiber JHC; Pekkan K; van Geuns R; Bourantas CV; Onuma Y; Serruys PW
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):409-418. PubMed ID: 30426299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early strut protrusion and late neointima thickness in the Absorb bioresorbable scaffold: a serial wall shear stress analysis up to five years.
    Tenekecioglu E; Torii R; Katagiri Y; Asano T; Modolo R; Miyazaki Y; Chichareon P; Poon EKW; Gijsen FJH; Thondapu V; van Klaveren D; Jonker H; Ooi A; Barlis P; Collet C; Onuma Y; Bourantas CV; Serruys PW
    EuroIntervention; 2019 Jul; 15(4):e370-e379. PubMed ID: 29969424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.
    Onuma Y; Honda Y; Asano T; Shiomi H; Kozuma K; Ozaki Y; Namiki A; Yasuda S; Ueno T; Ando K; Furuya J; Hanaoka KI; Tanabe K; Okada K; Kitahara H; Ono M; Kusano H; Rapoza R; Simonton C; Popma JJ; Stone GW; Fitzgerald PJ; Serruys PW; Kimura T
    JACC Cardiovasc Interv; 2020 Jan; 13(1):116-127. PubMed ID: 31918929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial shear stress 5 years after implantation of a coronary bioresorbable scaffold.
    Thondapu V; Tenekecioglu E; Poon EKW; Collet C; Torii R; Bourantas CV; Chin C; Sotomi Y; Jonker H; Dijkstra J; Revalor E; Gijsen F; Onuma Y; Ooi A; Barlis P; Serruys PW
    Eur Heart J; 2018 May; 39(18):1602-1609. PubMed ID: 29409057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
    Serruys PW; Onuma Y; Ormiston JA; de Bruyne B; Regar E; Dudek D; Thuesen L; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Dorange C; Veldhof S; Miquel-Hebert K; Rapoza R; García-García HM
    Circulation; 2010 Nov; 122(22):2301-12. PubMed ID: 21098436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference in haemodynamic microenvironment in vessels scaffolded with Absorb BVS and Mirage BRMS: insights from a preclinical endothelial shear stress study.
    Tenekecioglu E; Torii R; Bourantas C; Sotomi Y; Cavalcante R; Zeng Y; Collet C; Crake T; Suwannasom P; Onuma Y; Serruys PW
    EuroIntervention; 2017 Dec; 13(11):1327-1335. PubMed ID: 28590249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?
    Brugaletta S; Radu MD; Garcia-Garcia HM; Heo JH; Farooq V; Girasis C; van Geuns RJ; Thuesen L; McClean D; Chevalier B; Windecker S; Koolen J; Rapoza R; Miquel-Hebert K; Ormiston J; Serruys PW
    Atherosclerosis; 2012 Mar; 221(1):106-12. PubMed ID: 22209268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peri-strut low intensity areas and in-scaffold neointima growth after bioresorbable scaffold implantation in STEMI. A serial optical coherence tomography study.
    Ochijewicz D; Tomaniak M; Kołtowski L; Rdzanek A; Pietrasik A; Proniewska K; Partyka L; Dijsktra J; Huczek Z; Filipiak K; Opolski G; Kochman J
    Int J Cardiol; 2020 Aug; 312():27-32. PubMed ID: 32315682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold.
    Kochman J; Kołtowski Ł; Tomaniak M; Jąkała J; Proniewska K; Legutko J; Roleder T; Piertrasik A; Rdzanek A; Kochman W; Brugaletta S; Opolski G; Regar E
    EuroIntervention; 2018 Apr; 13(18):e2201-e2209. PubMed ID: 29155384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.
    Serruys PW; Ormiston J; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Chevalier B; Smits P; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Wasungu L; Ediebah D; Veldhof S; Onuma Y
    J Am Coll Cardiol; 2016 Feb; 67(7):766-76. PubMed ID: 26892411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of strut distribution on neointimal coverage of everolimus-eluting bioresorbable scaffolds: an optical coherence tomography study.
    Sato T; Jose J; Allai A; El-Mawardy M; Tölg R; Richardt G; Abdel-Wahab M
    J Thromb Thrombolysis; 2017 Aug; 44(2):161-168. PubMed ID: 28597206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients.
    Tröbs M; Achenbach S; Röther J; Klinghammer L; Schlundt C
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):872-880. PubMed ID: 27142643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strut protrusion and shape impact on endothelial shear stress: insights from pre-clinical study comparing Mirage and Absorb bioresorbable scaffolds.
    Tenekecioglu E; Sotomi Y; Torii R; Bourantas C; Miyazaki Y; Collet C; Crake T; Su S; Onuma Y; Serruys PW
    Int J Cardiovasc Imaging; 2017 Sep; 33(9):1313-1322. PubMed ID: 28365819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between peri-strut low intensity areas and vascular healing response after everolimus-eluting bioresorbable scaffold implantation: An optical coherence tomography study.
    Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
    J Cardiol; 2017 Apr; 69(4):606-612. PubMed ID: 27520757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
    Serruys PW; Chevalier B; Sotomi Y; Cequier A; Carrié D; Piek JJ; Van Boven AJ; Dominici M; Dudek D; McClean D; Helqvist S; Haude M; Reith S; de Sousa Almeida M; Campo G; Iñiguez A; Sabaté M; Windecker S; Onuma Y
    Lancet; 2016 Nov; 388(10059):2479-2491. PubMed ID: 27806897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between inflammatory biomarkers and neointimal response following elective implantation of the ABSORB bioresorbable vascular scaffold.
    Rampat R; Williams T; Mayo T; Mengozzi M; Ghezzi P; Hildick-Smith D; Cockburn J
    Coron Artery Dis; 2019 May; 30(3):183-187. PubMed ID: 30676384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neointimal response to everolimus-eluting bioresorbable scaffolds implanted at bifurcating coronary segments: insights from optical coherence tomography.
    Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):169-175. PubMed ID: 27757563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry.
    Pereira GTR; La Manna A; Ichibori Y; Vergara-Martel A; Ramos Nascimento B; Samdani AJ; Capodanno D; D'Agosta G; Gravina G; Venuti G; Tamburino C; F Attizzani G
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1767-1776. PubMed ID: 31175527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neointimal Healing Evaluated by Optical Coherence Tomography after Drug-Eluting Absorbable Metal Scaffold Implantation in de novo Native Coronary Lesions: Rationale and Design of the Magmaris-OCT Study.
    Karjalainen P; Paana T; Sia J; Nammas W
    Cardiology; 2017; 137(4):225-230. PubMed ID: 28467998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.